Alaska Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-29,787
Closed -$1.53M 128
2023
Q4
$1.53M Buy
+29,787
New +$1.56M 0.25% 27

Other funds holding BMY

Alaska Wealth Advisors's BMY Position: Q1 2024 in Review

Alaska Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 29,787 shares — an estimated $1.53M sold.

Alaska Wealth Advisors first reported a position in BMY in Q4 2023 and held it in 1 quarter. The position peaked at $1.53M in Q4 2023. 2,338 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Alaska Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • Alaska Wealth Advisors sold 29,787 Bristol-Myers Squibb shares in Q1 2024, an estimated $1.53M.
  • Alaska Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 1 quarter.
  • Alaska Wealth Advisors's Bristol-Myers Squibb position peaked at $1.53M in Q4 2023.
  • 2,338 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Alaska Wealth Advisors's 13F filing for Q1 2024, filed 18 Apr 2024.